A striking response of plasmablastic lymphoma of the oral cavity to bortezomib: a case report

被引:0
作者
Makoto Hirosawa
Hiroaki Morimoto
Ryo Shibuya
Shohei Shimajiri
Junichi Tsukada
机构
[1] Hematology,Department of Pathology and Oncology
[2] University of Occupational and Environmental Health,Department of Pathology and Cell Biology
[3] University of Occupational and Environmental Health,undefined
[4] University of Occupational and Environmental Health,undefined
关键词
Bortezomib; Plasmablastic lymphoma; Oral cavity;
D O I
10.1186/s40364-015-0053-0
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 78 条
[1]  
Delecluse HJ(1997)Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection Blood 89 1413-20
[2]  
Anagnostopoulos I(2015)The biology and treatment of plasmablastic lymphoma Blood 125 2323-30
[3]  
Dallenbach F(2004)CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients Ann Oncol 15 1673-9
[4]  
Hummel M(2010)Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma Leuk Lymphoma 51 2047-53
[5]  
Marafioti T(2010)Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics Am J Clin Pathol 134 710-9
[6]  
Schneider U(2011)HIV-negative plasmablastic lymphoma: not in the mouth Clin Lymphoma Myeloma Leuk 11 185-9
[7]  
Castillo JJ(2013)Bortezomib in plasmablastic lymphoma: a case report and review of the literature Onkologie 36 287-91
[8]  
Bibas M(2010)Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma Clin Lymphoma Myeloma Leuk 10 E43-6
[9]  
Miranda RN(2015)Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma Br J Haematol 82 490-2
[10]  
Teruya-Feldstein J(2009)AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib Eur J Haematol 28 e704-8